9/21/2020 8:09:18 AM
Teva Launches Two Digital Inhalers In The U.S.
9/15/2020 8:15:25 AM
Teva Says Results From 52-week, Parallel Group Study Evaluating AJOVY Injection Published In Neurology
9/8/2020 8:06:04 AM
Teva To Present New Data On AUSTEDO Tablets At MDS Virtual Congress 2020 And Psych Congress 2020 Virtual Experience
8/25/2020 9:02:14 PM
Federal Grand Jury In Philadelphia, Pennsylvania
returns Criminal Indictment Charging Teva USA
8/19/2020 8:02:45 AM
Teva Canada Announces Product Availability Of AJOVY 225 Mg Solution
8/18/2020 10:49:27 AM
Teva Sued By U.S. Over Alleged Kickbacks For Multiple Sclerosis Drug
8/5/2020 7:15:55 AM
Teva, Alvotech Enter Into Strategic Partnership For Commercialization In U.S. Of Five Biosimilar Product Candidates
8/5/2020 7:03:55 AM
Teva Pharma Q2 GAAP EPS $0.13; Non-GAAP EPS $0.55
7/30/2020 3:09:38 AM
Teva Announces New Strategy For Its Local Commercial Operations
7/29/2020 8:03:36 AM
Teva Reports New Drug Application Filing In Japan For AJOVY (fremanezumab) Injection
7/13/2020 8:03:43 AM
Teva Reports Availability Of ProAir Digihaler Inhalation Powder For Patients With Asthma And COPD
6/18/2020 8:05:04 AM
Teva Presents Analyses Examining Changes In Migraine Disability Outcome Measurements With AJOVY Injection